Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
How many voted NO?
I voted NO, but glad it will pass. I slapped my left side face, but smiled on the right side.
What really happened with Fernandez? That’s what I was really thinking.
Yes. RIP.
It’s all a game. SMH
Board directors were mostly picked personally by Charles himself. They will just rubber stamp everything he says.
Correct. Confirmed.
Interestingly, all of Flaker’s posts were removed by “Truth022809”. This means Flaker was not instructed by Fernandez or Caco not to argue with you guys here.
God bless Armen
The stock price will absolutely go up after merger. No RS is needed.
I think so too. But Armen is obviously out of his character.
I will ask him on LinkedIn.
I’m sure that’s just a parody account trying to stir the water.
If you search member names, there should be another real Armen’s user name still in there.
Are you sure that’s a real Armen’s account?
Gedi, can you confirm this?
Screenshot his words
By the way, I remember the company already closed the Telegram group.
I don’t think these are Armen’s words. You probably made it up.
I don’t think RS is needed. The combined company will rise to its fair value after 9/13.
I think so. The market will finally look at both companies as one. RXMD has been suppressed for too long. The combination should show the market its true value.
Q3 financials this week on 8/15.
Please send me in PM too. Thanks
The most interesting thing to me at this point is trying to understand why Armen agreed to the merger deal in 2022. His shares value dropped over 90% since then. His “heart is broken” in his own words. SMH
Armen just said this “Hi, I am still reviewing the report. Please be patient. In the meantime, you are welcome to share with me your questions or concerns that are specific to the valuation report.”
So let me know the questions you want to ask. I will forward to him.
Reply from Armen regarding the current stock performance:
“Hi, I am watching the same, and it breaks my heart to see the price of the stock at these levels. Especially after such strong first quarter. I know the company should be filing an S-4 shortly, so I hope to see the details of the anticipated transaction as well as the valuation report. Just like you, I and the rest of the shareholders are curious to see what it will say. Let’s connect after the filing and discuss it.”
Globalstar Europe Satellite Services Ltd., a wholly owned subsidiary of Globalstar, Inc. (NYSE American: GSAT), the next-generation international telecommunications infrastructure and technology provider, announced today that UK specialist wireless and satellite technology reseller,Global Telesat Communications (GTC), a subsidiary ofNextPlat Corp.(NASDAQ: NXPL), has surpassed the landmark milestone of 45,000 Globalstar devices sold.
https://telecomreseller.com/2024/05/23/global-telesat-communications-celebrates-45000-globalstar-device-sales-milestone/
One of Europe’s most successful resellers of Globalstar’s SPOT satellite-enabled GPS messengers, GTC supplies individuals and organisations with robust, practical and affordable SPOT Gen4, SPOT X Bluetooth and SPOT Trace. GTC’s wide range of organisational customers embraces an array of commercial and non-commercial entities to safeguard lone and at-risk workers. These include disaster relief agencies, energy and utilities suppliers such as Scottish Water, as well as civil and national defence organisations. GTC also supplies SPOT devices to numerous private and public organisations keen to protect staff involved in potentially hazardous forest management work.
Meanwhile, GTC continues to count outdoor adventurers and sportspeople among its growing customer base for popular SPOT products.
All these users recognise that whenever their activities take them beyond the reach of existing cellular networks or other terrestrial communications systems, only satellite technology can provide trustworthy and ubiquitous connectivity.
“SPOT devices have an enduring appeal, even in today’s competitive marketplace,” says David Phipps, CEO of Global Operations of NextPlat Corp, and Managing Director of GTC. “Their inherent simplicity, easy operation and economical price make SPOT an ideal choice for users in a wide variety of applications.”
Phipps also points to network reliability and reach as key drivers of SPOT’s ongoing market success: “Globalstar’s robust network and near-global coverage are also key factors in why consumers and organisations choose SPOT,” he says.
Thanks to the SPOT family of satellite GPS messengers, this wide range of users can instantly transmit their GPS location via satellite, and check in with colleagues, friends and family with SPOT’s messaging function. With SPOT’s one-touch SOS button, faced with an emergency, users can summon colleagues or first responders via SPOT’s 24/7 Search and Rescue Services.
Globalstar Europe Satellite Services Ltd., a wholly owned subsidiary of Globalstar, Inc. (NYSE American: GSAT), the next-generation international telecommunications infrastructure and technology provider, announced today that UK specialist wireless and satellite technology reseller,Global Telesat Communications (GTC), a subsidiary ofNextPlat Corp.(NASDAQ: NXPL), has surpassed the landmark milestone of 45,000 Globalstar devices sold.
https://telecomreseller.com/2024/05/23/global-telesat-communications-celebrates-45000-globalstar-device-sales-milestone/
One of Europe’s most successful resellers of Globalstar’s SPOT satellite-enabled GPS messengers, GTC supplies individuals and organisations with robust, practical and affordable SPOT Gen4, SPOT X Bluetooth and SPOT Trace. GTC’s wide range of organisational customers embraces an array of commercial and non-commercial entities to safeguard lone and at-risk workers. These include disaster relief agencies, energy and utilities suppliers such as Scottish Water, as well as civil and national defence organisations. GTC also supplies SPOT devices to numerous private and public organisations keen to protect staff involved in potentially hazardous forest management work.
Meanwhile, GTC continues to count outdoor adventurers and sportspeople among its growing customer base for popular SPOT products.
All these users recognise that whenever their activities take them beyond the reach of existing cellular networks or other terrestrial communications systems, only satellite technology can provide trustworthy and ubiquitous connectivity.
“SPOT devices have an enduring appeal, even in today’s competitive marketplace,” says David Phipps, CEO of Global Operations of NextPlat Corp, and Managing Director of GTC. “Their inherent simplicity, easy operation and economical price make SPOT an ideal choice for users in a wide variety of applications.”
Phipps also points to network reliability and reach as key drivers of SPOT’s ongoing market success: “Globalstar’s robust network and near-global coverage are also key factors in why consumers and organisations choose SPOT,” he says.
Thanks to the SPOT family of satellite GPS messengers, this wide range of users can instantly transmit their GPS location via satellite, and check in with colleagues, friends and family with SPOT’s messaging function. With SPOT’s one-touch SOS button, faced with an emergency, users can summon colleagues or first responders via SPOT’s 24/7 Search and Rescue Services.
Progressive Care is a great company. Not so sure about satellite
Need a major M/A in healthcare asap. They should focus on Progressive Care instead of satellite.
NextPlat satellite biz is losing money. After merger, if they can get rid of that part and show huge profit from Progressive Care, and possibly with another major M/A in healthcare, then this will get some serious attention on Naz.
Armen replied my LinkedIn message.
“I greatly appreciate your kind words and value your support for this company over the last 9 years. It’s been an amazing journey, and RXMD wouldn’t be where it is today without yours and all the other long-term shareholders' support. I am very grateful for that. As you probably saw in the 10-K report, the company had a strong year. Our team worked very hard and continues to do the same. As a shareholder of this company, I hope everything else will fall into the right place. ”
It is an unfair game that Charles has played with RXMD shareholders since he became the CEO. Their intention has always been to convert the RXMD shares at a much lower ratio than what they would have paid for before the RS when the SP was still much higher, equivalent to about $5-6 today. It is what it is. I still wish for the best outcome when all these transactions are finally over.
I wish for the peace on the planet Earth. I wish for the success of Progressive Care. I wish a great weekend for everyone.
The combined entity will be named Progressive Care. It doesn’t sound like anything to do with satellite. Acquisition of outfitter probably is just for the expansion of that part of business, nothing to do with healthcare.
I think the goal is still to spin off satellite biz after merger. Then they will do another major M/A with a healthcare company with the $29M cash they have in hand.
Progressive Care Inc. Announces Record Full Year 2023 Results with Revenues of $49.7 Million, an Increase of 22% with Annual Gross Margins of 30%
APRIL 11, 2024
https://www.progressivecareus.com/post/progressive-care-inc-announces-record-full-year-2023-results-with-revenues-of-49-7-million-an-increase-of-22-with-annual-gross-margins-of-30
The Companyreported record annual revenues of approximately $49.7 million, a 22% increase from results reported for the year ended December 31, 2022, driven by strong growth at its PharmcoRx pharmacies and the addition of multiple new 340B contracts in the second half of 2023.
“Progressive Care’s significant growth in 2023 reflects its continuing commitment to ensuring strong patient medical adherence through highly specialized care and its proven ability to support the unique needs of 340B covered entities. I am pleased with our team’s success in greatly strengthening the Company’s financial foundation and driving improved operational performance. We continue to seek opportunities to expand our pharmacy operations with new programs, such as the OTC benefit programs announced last year, and add additional clients within the 340B space,” said Charles M. Fernandez, Chairman and CEO of Progressive Care Inc.
Progressive Care Inc. Announces Record Full Year 2023 Results with Revenues of $49.7 Million, an Increase of 22% with Annual Gross Margins of 30%
APRIL 11, 2024
https://www.progressivecareus.com/post/progressive-care-inc-announces-record-full-year-2023-results-with-revenues-of-49-7-million-an-increase-of-22-with-annual-gross-margins-of-30
The Companyreported record annual revenues of approximately $49.7 million, a 22% increase from results reported for the year ended December 31, 2022, driven by strong growth at its PharmcoRx pharmacies and the addition of multiple new 340B contracts in the second half of 2023.
“Progressive Care’s significant growth in 2023 reflects its continuing commitment to ensuring strong patient medical adherence through highly specialized care and its proven ability to support the unique needs of 340B covered entities. I am pleased with our team’s success in greatly strengthening the Company’s financial foundation and driving improved operational performance. We continue to seek opportunities to expand our pharmacy operations with new programs, such as the OTC benefit programs announced last year, and add additional clients within the 340B space,” said Charles M. Fernandez, Chairman and CEO of Progressive Care Inc.
NextPlat Corp (the “Registrant”) is unable to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 within the prescribed time period without undue hardship and expense to the Registrant. Since July 1, 2023, the Registrant has consolidated the financials results of Progressive Care Inc. ("Progressive Care") in the Registrant's financial statements. Progressive Care is itself a public company that must file audited financial statements in connection with its Annual Report on Form 10-K. Progressive Care's registered public accounting firm has notified Progressive Care that it needs additional time to complete its audit of Progressive Care's financial statements relating to goodwill impairment testing and long-lived asset impairment analysis. Accordingly, given that Progressive Care's financial results flow through the Registrant's financial statements, the Registrant requires additional time to complete its annual financial statements. Progressive Care's independent registered public accounting firm has indicated that it expects to complete its audit of Progressive Care's financials by Wednesday, April 3, 2024. The Registrant expects to file its Annual Report on Form 10-K by Friday, April, 5, 2024, and in no event later than fifteen days after its original prescribed due date as provided by Exchange Act Rule 12b-25.
Interesting both NXPL and RXMD haven’t filed 10K yet.